 |
|
Intravaginal isonicotinic acid hydrazide (INH) versus misoprostol for cervical ripening prior to hysteroscopy
Ladan Haghighi, Zahra Najmi, Samaneh Rokhgireh, Yousef Moradi
Obstet Gynecol Sci. 2020;63(4):514-520. Published online 2020 Jun 19 DOI: https://doi.org/10.5468/ogs.19170
|
|
Citations to this article as recorded by
 A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery
Nahla W. Shady, Hassan A. Farouk, Hany F. Sallam
Contraception.2023; 120: 109788. CrossRef Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients: A Randomized Double-Blinded Clinical Trial
Nahla W. Shady, Hassan A. Farouk, Hany F. Sallam
Journal of Gynecologic Surgery.2023; 39(1): 43. CrossRef Isonicotinic acid hydrazide (INH) versus extra-amniotic saline infusion (EASI) for cervical ripening at term: a randomised controlled trial
Ladan Haghighi, Behnaz Mohabbatian, Zahra Najmi, Samaneh Rokhgireh, Samira Saadatjoo, Yousef Moradi, Mojgan Mokhtari
Journal of Obstetrics and Gynaecology.2022; 42(7): 2693. CrossRef Pain Management during Office Hysteroscopy: An Evidence-Based Approach
Giovanni Buzzaccarini, Luis Alonso Pacheco, Amerigo Vitagliano, Sergio Haimovich, Vito Chiantera, Péter Török, Salvatore Giovanni Vitale, Antonio Simone Laganà, Jose Carugno
Medicina.2022; 58(8): 1132. CrossRef
|